drugset / Trial / NCT03948828

Clinical Study of NK Cells in the Treatment of Severe Endometriosis

NCT03948828 ↗

Phase 1 Unknown 60 enrolled Shenzhen People's Hospital
Non-randomizedParallel-groupOpen-labelTreatment

Summary

Dysfunction of natural koller cells (NK cells) is an important factor in the development of endometriosis. NK cell therapy was applied to treat severe endometriosis, which is an exploration of the pathogenesis of this refractory disease.

Timeline

Start
2019-06-01
Primary completion
2022-05-31
Completion
2022-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Autologous NK cell therapy Cell therapy — —

Indications